FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills
Միայն փաստեր

FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills

Ամփոփում

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine tablets due to potency concerns.

The U.S. Food and Drug Administration announced a voluntary recall of telmisartan and amlodipine blood pressure tablets distributed by Mylan Pharmaceuticals. The recall covers 40-mg telmisartan and 5-mg amlodipine tablets packaged in 30-count bottles.

The FDA said the affected lots contain higher than specified amounts of telmisartan, making the drugs more potent than intended. Lot numbers 3228113, 3228114, 3228115 (expiring Oct. 31, 2026) and 3228120, 3228121 (expiring Nov. 30, 2026) are included, affecting over 21,000 bottles.

The agency classified the recall as Class III, indicating that use of the medication is not expected to cause serious health consequences. Patients are advised to verify lot numbers and expiration dates, discontinue use of any recalled product, and consult a healthcare professional. Refunds may be available through the dispensing pharmacy.

For additional information, the FDA can be reached at 1-888-INFO-FDA (1-888-463-6332).

Աղբյուր

Yahoo

Շարունակեք կարդալ — անվճար

Ստեղծեք անվճար հաշիվ՝ նորություններին հետևելու համար։ Քարտ չի պահանջվում։